カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

細胞培養培地の世界市場予測（～2028）：種類別、用途別、エンドユーザー別、地域別

◆英語タイトル：Cell Culture Media Market by Type (Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application (Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User (Pharma, Biotech) & Region - Global Forecast to 2028
	◆商品コード：BT8052-23 ◆発行会社（リサーチ会社）：MarketsandMarkets ◆発行日：2023年7月24日 ◆ページ数：316 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後24時間以内） ◆調査対象地域：グローバル ◆産業分野：バイオテクノロジー

◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥742,500	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥997,500	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,222,500	見積依頼/購入/質問フォーム

★MarketsandMarketsに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

"世界の細胞培養培地市場は2023年の62億米ドルから2028年には130億米ドルに達すると予測、予測期間中のCAGRは16.0%" mabsとバイオシミラーの需要増加、無血清培地の採用増加は、市場成長を予測する主な要因の一部です。細胞ベースのワクチン採用の増加、市場における新製品上市のための主要市場参入企業による投資の増加は、今後数年間の市場成長を促進すると予想される主要な要素の一部です。

"タイプ別では、無血清培地セグメントが予測期間中に大きなCAGRで成長すると予測"
2022年には、無血清培地セグメントが市場で最大のシェアを占めました。無血清培地は、細胞培養により制御された明確な環境を提供するため、血清含有培地の代替として開発されました。これらの培地は通常、細胞の成長と増殖に必要な成長因子、ホルモン、ビタミン、ミネラル、その他の栄養素を規定濃度で添加した基礎培地で構成されています。様々な利点があるため、エンドユーザーの間で無血清培地への需要が増加しており、この要因がセグメント成長に影響を与えています。

"アジア太平洋：細胞培養培地市場で最も成長著しい地域"
細胞培養培地市場は、北米、欧州、アジア太平洋地域、ラテンアメリカ（LATAM）、中東・アフリカ（MEA）に区分されます。アジア太平洋市場は、予測期間中に17.5%という最高のCAGRを記録する見込みです。細胞培養ベースのワクチン製造に対する規制当局の好意的な支援やガイドライン、ワクチンの適度な製造コスト、アジア太平洋地域の主要市場プレイヤーによる地理的拡大の重視などが、アジア太平洋地域の成長をより速いペースで予測する主な要因の一部です。

本レポートで参照した主な参加者の内訳は以下の通りです：
-回答者別：供給側80％、需要側20
-役職別：管理職：45％、CXOおよび取締役：30％、経営幹部：25
-地域別：北米20％、欧州10％、アジア太平洋55％、中南米10％、中東・アフリカ5%

世界の細胞培養培地市場における主要企業は、Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), Miltenyi Biotec (Germany), HiMedia Laboratories Pvt. Ltd. (India), STEMCELL Technologies Inc. (Canada), Biologos LLC (US), Cell Applications, Inc. (US), Caisson Laboratories Inc. (US), PromoCell GmbH (Germany), Cell Biologics, Inc. (US), InvivoGen (France), PAN-Biotech GmbH (Germany), Cellular Technology Limited, LLC (US), ZenBio, Inc. (US), Athena Environmental Sciences, Inc. (US), Cyagen Biosciences (US), Biowest SAS (France), WELGENE Inc.(South Korea), KCell Biosciences (South Korea), and Akron Biotech (US)などがあります。調査範囲この調査レポートは、細胞培養培地市場を分析し、市場規模と今後の成長可能性を推定することを目的としています。また、同市場における主要企業の会社概要、製品提供、最近の動向とともに、詳細な競合分析も掲載しています。

レポート購入の理由
本レポートは、細胞培養培地市場全体とそのサブセグメントについて、最も近似した収益数値を提供することで、市場リーダー/新規参入者の助けとなります。また、利害関係者が競争状況をより良く理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置づけ、適切な市場参入戦略を立てるのにも役立ちます。本レポートは、利害関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します：
-主な推進要因の分析（製薬企業の研究開発費、細胞ベースのワクチンのための新たな細胞培養技術、モノクローナル抗体とバイオシミラーの需要増加、幹細胞研究の成長、市場参入企業による新しい細胞培養培地の発売細胞培養培地市場の成長に影響を与える阻害要因（高価な細胞生物学研究用製品、細胞生物学研究に関する倫理的懸念）、機会（3D細胞培養の進展）、課題（小規模企業や新規参入企業の生き残り）
-製品開発/イノベーション：細胞培養培地市場における今後の動向、研究開発活動、新製品発売に関する詳細な洞察
-市場開発：有利な市場に関する包括的情報 - 当レポートでは、様々な地域の細胞培養培地市場を分析
-市場の多様化：新製品、未開拓の地域、最近の開発、細胞培養培地市場における投資に関する詳細な情報
-競合評価：Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), Miltenyi Biotec (Germany), HiMedia Laboratories Pvt. Ltd. (India), STEMCELL Technologies Inc. (Canada), Biologos LLC (US)などの主要企業の市場シェア、成長戦略、製品提供の詳細な評価

1. はじめに
2. 調査方法
3. エグゼクティブサマリー
4. プレミアムインサイト
5. 市場概要
6. 細胞培養培地市場：タイプ別
7. 細胞培養培地市場：用途別
8. 細胞培養培地市場：エンドユーザー別
9. 細胞培養培地市場：地域別
10. 競争状況
11. 企業情報
12. 付録

❖ レポートの目次 ❖

1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS & EXCLUSIONS 28
1.3 MARKET SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 YEARS CONSIDERED 30
1.4 CURRENCY 30
1.5 LIMITATIONS 30
1.6 STAKEHOLDERS 31
1.7 SUMMARY OF CHANGES 31
1.8 RECESSION IMPACT 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 1 CELL CULTURE MEDIA MARKET: RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.2 PRIMARY RESEARCH 34
FIGURE 2 BREAKDOWN OF PRIMARIES: CELL CULTURE MEDIA MARKET 35
2.2 MARKET ESTIMATION METHODOLOGY 36
FIGURE 3 CELL CULTURE MEDIA MARKET SIZE ESTIMATION, 2022 36
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1—COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2022 37
FIGURE 5 ILLUSTRATIVE EXAMPLE OF MERCK KGAA: REVENUE SHARE ANALYSIS (2022) 37
FIGURE 6 KEY INDUSTRY INSIGHTS 38
2.3 MARKET GROWTH RATE PROJECTIONS 39
FIGURE 7 CELL CULTURE MEDIA MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 40
FIGURE 8 CELL CULTURE MEDIA MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 40
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 41
FIGURE 9 DATA TRIANGULATION METHODOLOGY 41
2.5 RESEARCH ASSUMPTIONS 42
2.6 RISK ANALYSIS 42
2.7 RECESSION IMPACT 42
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2022–2028 (% GROWTH) 42
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 43
TABLE 3 US HEALTH EXPENDITURE, 2023–2030 (USD MILLION) 43
3 EXECUTIVE SUMMARY 44
FIGURE 10 CELL CULTURE MEDIA MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 44
FIGURE 11 CELL CULTURE MEDIA MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 45
FIGURE 12 CELL CULTURE MEDIA MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 46
FIGURE 13 CELL CULTURE MEDIA MARKET: GEOGRAPHICAL SNAPSHOT 47
4 PREMIUM INSIGHTS 48
4.1 CELL CULTURE MEDIA MARKET OVERVIEW 48
FIGURE 14 RISING R&D SPENDING IN PHARMA COMPANIES AND EMERGING CELL CULTURE TECHNOLOGIES FOR CELL-BASED VACCINES TO DRIVE MARKET 48
4.2 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE AND COUNTRY (2022) 49
FIGURE 15 SERUM-FREE MEDIA SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN CELL CULTURE MEDIA MARKET IN 2022 49
4.3 CELL CULTURE MEDIA MARKET SHARE, BY APPLICATION, 2023 VS. 2028 50
FIGURE 16 BIOPHARMACEUTICAL PRODUCTION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028 50
4.4 CELL CULTURE MEDIA MARKET, BY END USER, 2022 (USD MILLION) 50
FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED MARKET IN 2022 50
4.5 CELL CULTURE MEDIA MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 51
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 19 CELL CULTURE MEDIA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
TABLE 4 CELL CULTURE MEDIA MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 53
5.2.1.1 Emerging cell culture technologies for cell-based vaccines 53
TABLE 5 APPROVED CELL CULTURE-BASED VACCINES FOR INFLUENZA 54
5.2.1.2 Increasing demand for monoclonal antibodies and biosimilars 54
TABLE 6 APPROVED MONOCLONAL ANTIBODIES BY US FDA FOR THERAPEUTIC USE 54
5.2.1.3 Launch of new cell culture media products by market players 55
5.2.1.4 Rising R&D investments by pharmaceutical companies 56
FIGURE 20 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 56
5.2.1.5 Increasing demand for serum- and animal component-free media 56
5.2.1.6 Growth in stem cell research 57
5.2.1.7 Growing focus on personalized medicine 58
TABLE 7 GROWTH IN NUMBER OF PERSONALIZED MEDICATIONS, 2015–2022 58
5.2.2 RESTRAINTS 58
5.2.2.1 Expensive cell biology research products 58
5.2.2.2 Ethical concerns regarding cell biology research 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Advancements in 3D cell culture 59
5.2.3.2 Increasing incidence of infectious diseases and outbreaks of pandemics 60
TABLE 8 PROJECTED INCREASE IN COUNT OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035 60
TABLE 9 ESTIMATED COUNT OF NEW CASES OF CANCER, EXCLUDING NON-MELANOMA SKIN CANCER, AGE (0–85+), 2020–2040 60
5.2.3.3 Emerging markets 61
5.2.4 CHALLENGES 61
5.2.4.1 Survival of small players and new entrants 61
5.3 IMPACT OF UNCERTAINTIES ON CELL CULTURE MEDIA MARKET 62
FIGURE 21 CELL CULTURE MEDIA MARKET: SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH 62
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 62
FIGURE 22 REVENUE SHIFT & NEW REVENUE POCKETS FOR CELL CULTURE MEDIA PROVIDERS 62
5.5 PATENT ANALYSIS 63
FIGURE 23 CELL CULTURE MEDIA MARKET: PATENT APPLICATIONS, JANUARY 2012–JUNE 2023 63
TABLE 10 CELL CULTURE MEDIA MARKET: INDICATIVE LIST OF PATENTS 64
5.6 VALUE CHAIN ANALYSIS 64
FIGURE 24 VALUE CHAIN ANALYSIS OF CELL CULTURE MEDIA MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE 64
5.7 SUPPLY CHAIN ANALYSIS 65
FIGURE 25 CELL CULTURE MEDIA MARKET: SUPPLY CHAIN ANALYSIS 66
5.8 CELL CULTURE MEDIA MARKET: ECOSYSTEM ANALYSIS 66
TABLE 11 CELL CULTURE MEDIA MARKET: ECOSYSTEM 67
5.9 KEY CONFERENCES AND EVENTS, 2023–2024 69
TABLE 12 CELL CULTURE MEDIA MARKET: CONFERENCES AND EVENTS 69
5.10 PRICING ANALYSIS 70
5.10.1 AVERAGE SELLING PRICE TRENDS OF DIFFERENT TYPES OF MEDIA/1000L IN DEVELOPED AND DEVELOPING REGIONS (2022) 70
TABLE 13 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA (2022) 70
5.11 TRADE ANALYSIS (HS CODES) 71
TABLE 14 EXPORT DATA FOR PREPARED CULTURE MEDIA, BY COUNTRY, 2018–2022 (USD THOUSAND) 71
TABLE 15 IMPORT DATA FOR PREPARED CULTURE MEDIA, BY COUNTRY, 2018–2022 (USD THOUSAND) 72
5.12 PORTER’S FIVE FORCES ANALYSIS 73
TABLE 16 CELL CULTURE MEDIA MARKET: PORTER’S FIVE FORCES ANALYSIS 73
5.12.1 THREAT OF NEW ENTRANTS 74
5.12.2 THREAT OF SUBSTITUTES 74
5.12.3 BARGAINING POWER OF SUPPLIERS 74
5.12.4 BARGAINING POWER OF BUYERS 74
5.13 REGULATORY ANALYSIS 75
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 76
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF CELL CULTURE MEDIA PRODUCTS 76
5.14.2 BUYING CRITERIA FOR CELL CULTURE MEDIA 77
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 77
6 CELL CULTURE MEDIA MARKET, BY TYPE 78
6.1 INTRODUCTION 79
TABLE 17 CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 79
6.1.1 SERUM-FREE MEDIA 79
TABLE 18 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS 80
TABLE 19 SERUM-FREE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 80
TABLE 20 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 21 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 22 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 23 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 24 SERUM-FREE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 82
6.1.1.1 CHO media 83
6.1.1.1.1 Growing adoption of CHO media in biopharmaceutical companies to drive market 83
TABLE 25 CHO MEDIA OFFERED BY KEY MARKET PLAYERS 83
TABLE 26 CHO MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 27 NORTH AMERICA: CHO MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 28 EUROPE: CHO MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 29 ASIA PACIFIC: CHO MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 30 LATIN AMERICA: CHO MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
6.1.1.2 HEK 293 media 85
6.1.1.2.1 Advantages of HEK 293 cell lines to boost market 85
TABLE 31 HEK 293 MEDIA OFFERED BY KEY MARKET PLAYERS 86
TABLE 32 HEK 293 MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 33 NORTH AMERICA: HEK 293 MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 34 EUROPE: HEK 293 MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 35 ASIA PACIFIC: HEK 293 MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 36 LATIN AMERICA: HEK 293 MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
6.1.1.3 BHK media 88
6.1.1.3.1 Wide applications of BHK media in production of recombinant proteins to bolster market 88
TABLE 37 BHK MEDIA OFFERED BY KEY MARKET PLAYERS 88
TABLE 38 BHK MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 39 NORTH AMERICA: BHK MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 40 EUROPE: BHK MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 41 ASIA PACIFIC: BHK MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 42 LATIN AMERICA: BHK MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
6.1.1.4 Vero cell media 90
6.1.1.4.1 Increasing role of Vero cells in research pertaining to viral vaccines to boost market 90
TABLE 43 VERO CELL MEDIA OFFERED BY KEY MARKET PLAYERS 91
TABLE 44 VERO CELL MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 45 NORTH AMERICA: VERO CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 46 EUROPE: VERO CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 47 ASIA PACIFIC: VERO CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 48 LATIN AMERICA: VERO CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.1.1.5 Serum-free stem cell media 93
6.1.1.5.1 Availability of funding for stem cell research to propel market 93
TABLE 49 SERUM-FREE STEM CELL MEDIA OFFERED BY KEY MARKET PLAYERS 94
TABLE 50 SERUM-FREE STEM CELL MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 51 NORTH AMERICA: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 52 EUROPE: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 53 ASIA PACIFIC: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 54 LATIN AMERICA: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
6.1.1.6 Immune cell media 96
6.1.1.6.1 Growing demand for research on immune cells to fuel market 96
TABLE 55 IMMUNE CELL MEDIA OFFERED BY KEY MARKET PLAYERS 97
TABLE 56 IMMUNE CELL MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 57 NORTH AMERICA: IMMUNE CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 58 EUROPE: IMMUNE CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 59 ASIA PACIFIC: IMMUNE CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 60 LATIN AMERICA: IMMUNE CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
6.1.1.7 Insect cell media 99
6.1.1.7.1 Growing adoption of insect cell media for heterologous protein expression to drive market 99
TABLE 61 INSECT CELL MEDIA OFFERED BY KEY MARKET PLAYERS 99
TABLE 62 INSECT CELL MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 100
TABLE 63 NORTH AMERICA: INSECT CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 64 EUROPE: INSECT CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 65 ASIA PACIFIC: INSECT CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 66 LATIN AMERICA: INSECT CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
6.1.1.8 Other serum-free media 102
TABLE 67 OTHER SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS 102
TABLE 68 OTHER SERUM-FREE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 69 NORTH AMERICA: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 70 EUROPE: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 71 ASIA PACIFIC: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 72 LATIN AMERICA: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
6.1.2 CLASSICAL MEDIA & SALTS 104
6.1.2.1 Wide use of classical media & salts across all types of cell culture applications to boost market 104
TABLE 73 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS 105
TABLE 74 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 75 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 76 EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 77 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 78 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.1.3 STEM CELL CULTURE MEDIA 107
6.1.3.1 Increasing collaborations for stem cell research to bolster market 107
TABLE 79 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS 108
TABLE 80 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 81 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 82 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 83 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 84 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
6.1.4 CHEMICALLY DEFINED (CD) MEDIA 110
6.1.4.1 Ability of CD media to increase reproducibility to drive market 110
TABLE 85 CHEMICALLY DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS 111
TABLE 86 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 87 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 88 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 89 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 90 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
6.1.5 SPECIALTY MEDIA 113
6.1.5.1 Ability of primary cells to proliferate in specialty media to fuel market 113
TABLE 91 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS 113
TABLE 92 SPECIALTY MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 93 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 94 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 95 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 96 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
6.1.6 OTHER CELL CULTURE MEDIA 115
TABLE 97 OTHER CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS 116
TABLE 98 OTHER CELL CULTURE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 99 NORTH AMERICA: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 100 EUROPE: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 101 ASIA PACIFIC: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 102 LATIN AMERICA: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
7 CELL CULTURE MEDIA MARKET, BY APPLICATION 119
7.1 INTRODUCTION 120
TABLE 103 CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 120
7.2 BIOPHARMACEUTICAL PRODUCTION 120
TABLE 104 CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 105 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 106 EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 107 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 108 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 109 CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 123
7.2.1 MONOCLONAL ANTIBODY PRODUCTION 123
7.2.1.1 Growing demand for monoclonal antibody production to fuel market growth 123
TABLE 110 INDICATIVE LIST OF APPROVED ANTIBODY PRODUCTS PRODUCED IN CHO CELLS 124
TABLE 111 INDICATIVE LIST OF MONOCLONAL ANTIBODIES WITH FDA AUTHORIZATION 124
TABLE 112 CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 113 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 114 EUROPE: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 115 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 116 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 127
7.2.2 VACCINE PRODUCTION 127
7.2.2.1 Growing government support for vaccine production to boost market 127
TABLE 117 NIH FUNDING FOR VACCINE RESEARCH, 2020–2024 (USD MILLION) 128
TABLE 118 CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 119 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 120 EUROPE: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 121 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 122 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 130
7.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS 130
TABLE 123 CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 124 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 125 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 126 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 127 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 133
7.3 DIAGNOSTICS 133
7.3.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET 133
TABLE 128 CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 129 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 130 EUROPE: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 131 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 132 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 136
7.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE 136
TABLE 133 CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION) 137
TABLE 134 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 135 EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 136 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 137 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 138 CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 139
7.4.1 CELL & GENE THERAPY 139
7.4.1.1 Increasing adoption of cell and gene therapies for treating patients to propel market 139
TABLE 139 CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY REGION, 2021–2028 (USD MILLION) 140
TABLE 140 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 141 EUROPE: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 142 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 143 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
7.4.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS 142
TABLE 144 CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 145 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 146 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 147 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 148 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 145
7.5 DRUG SCREENING & DEVELOPMENT 145
7.5.1 ADOPTION OF CELL-BASED ASSAYS IN DRUG DISCOVERY TO BOOST MARKET 145
TABLE 149 CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 146
TABLE 150 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 151 EUROPE: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 152 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 153 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 148
7.6 OTHER APPLICATIONS 148
TABLE 154 CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 149
TABLE 155 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 156 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 157 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 158 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 151

8 CELL CULTURE MEDIA MARKET, BY END USER 152
8.1 INTRODUCTION 153
TABLE 159 CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 153
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 153
8.2.1 INCREASING RESEARCH EXPENDITURE BY PHARMA AND BIOTECH COMPANIES TO DRIVE MARKET 153
TABLE 160 PHARMA & BIOTECH SECTOR: RECENT DEVELOPMENTS 154
TABLE 161 CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 154
TABLE 162 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 163 EUROPE: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 164 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 165 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 156
8.3 HOSPITALS & DIAGNOSTIC LABORATORIES 156
8.3.1 INCREASING APPLICATIONS OF CELL CULTURE MEDIA IN DISEASE DIAGNOSIS TO BOOST MARKET 156
TABLE 166 CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 157
TABLE 167 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 168 EUROPE: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 169 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 170 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 159
8.4 RESEARCH & ACADEMIC INSTITUTES 159
8.4.1 GROWING PREVALENCE OF CANCER AND INCREASING RESEARCH FUNDING TO PROPEL MARKET 159
TABLE 171 CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 160
TABLE 172 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 173 EUROPE: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 174 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 175 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 162

8.5 OTHER END USERS 162
TABLE 176 CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 177 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 178 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 179 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 180 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 165
9 CELL CULTURE MEDIA MARKET, BY REGION 166
9.1 INTRODUCTION 167
TABLE 181 CELL CULTURE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 167
9.2 NORTH AMERICA 167
9.2.1 RECESSION IMPACT 168
FIGURE 28 NORTH AMERICA: CELL CULTURE MEDIA MARKET SNAPSHOT 169
TABLE 182 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 183 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 184 NORTH AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 185 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 186 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 187 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 188 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 173
9.2.2 US 173
9.2.2.1 Growing pharmaceutical and biotechnology sector to drive market 173
TABLE 189 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 190 US: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 191 US: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 175
TABLE 192 US: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 193 US: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 194 US: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 176
9.2.3 CANADA 176
9.2.3.1 Increase in stem cell research funding in Canada to fuel market growth 176
TABLE 195 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 196 CANADA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 197 CANADA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178
TABLE 198 CANADA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 199 CANADA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 200 CANADA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 179
9.3 EUROPE 180
9.3.1 RECESSION IMPACT 180
TABLE 201 EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 202 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 203 EUROPE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 204 EUROPE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 205 EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 206 EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 207 EUROPE: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 183
9.3.2 GERMANY 184
9.3.2.1 Strong growth in biotechnology industry in Germany to drive market growth 184
TABLE 208 GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 209 GERMANY: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 210 GERMANY: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185
TABLE 211 GERMANY: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 212 GERMANY: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 213 GERMANY: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 186
9.3.3 UK 187
9.3.3.1 Advancements in life sciences sector to boost market 187
TABLE 214 UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 215 UK: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 216 UK: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 188
TABLE 217 UK: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 218 UK: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 219 UK: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 189
9.3.4 FRANCE 190
9.3.4.1 Increase in government funding for life science research to drive market 190
TABLE 220 FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 221 FRANCE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 222 FRANCE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 191
TABLE 223 FRANCE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 224 FRANCE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 225 FRANCE: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 192

9.3.5 ITALY 193
9.3.5.1 Growing support for life science research in Italy to fuel market growth 193
TABLE 226 ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 227 ITALY: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 228 ITALY: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 194
TABLE 229 ITALY: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 230 ITALY: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 231 ITALY: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 195
9.3.6 SPAIN 196
9.3.6.1 Advancement of translational personalized medicine to support market growth in Spain 196
TABLE 232 SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 233 SPAIN: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 234 SPAIN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 197
TABLE 235 SPAIN: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 236 SPAIN: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 237 SPAIN: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 198
9.3.7 REST OF EUROPE 199
TABLE 238 REST OF EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 239 REST OF EUROPE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 240 REST OF EUROPE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 200
TABLE 241 REST OF EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 242 REST OF EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 243 REST OF EUROPE: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 201
9.4 ASIA PACIFIC 202
9.4.1 RECESSION IMPACT 202
FIGURE 29 ASIA PACIFIC: CELL CULTURE MEDIA MARKET SNAPSHOT 203
TABLE 244 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 204
TABLE 245 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 246 ASIA PACIFIC: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 247 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 205
TABLE 248 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 249 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 250 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 206
9.4.2 CHINA 207
9.4.2.1 Increasing demand for monoclonal antibodies to propel market 207
TABLE 251 CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 252 CHINA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 253 CHINA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 208
TABLE 254 CHINA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 255 CHINA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 256 CHINA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 209
9.4.3 JAPAN 210
9.4.3.1 Strategic developments by companies to contribute to market growth 210
TABLE 257 JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 258 JAPAN: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 259 JAPAN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 212
TABLE 260 JAPAN: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 261 JAPAN: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 262 JAPAN: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 213
9.4.4 INDIA 213
9.4.4.1 Favorable government regulations and support to augment market growth 213
TABLE 263 INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 264 INDIA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 265 INDIA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 215
TABLE 266 INDIA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 267 INDIA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 268 INDIA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 216
9.4.5 SOUTH KOREA 216
9.4.5.1 Increasing pharmaceutical and biotech R&D investment to bolster market 216
TABLE 269 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 270 SOUTH KOREA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 271 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 218
TABLE 272 SOUTH KOREA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 273 SOUTH KOREA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 274 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 219
9.4.6 REST OF ASIA PACIFIC 220
TABLE 275 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 276 REST OF ASIA PACIFIC: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 277 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 221
TABLE 278 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 279 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 280 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 223
9.5 LATIN AMERICA 223
9.5.1 RECESSION IMPACT 223
TABLE 281 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 224
TABLE 282 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 283 LATIN AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 284 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 225
TABLE 285 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 286 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 287 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 226
9.5.2 BRAZIL 227
9.5.2.1 Expanding pharmaceutical market in Brazil to boost market 227
TABLE 288 BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 289 BRAZIL: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 290 BRAZIL: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 228
TABLE 291 BRAZIL: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 292 BRAZIL: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 293 BRAZIL: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 229
9.5.3 MEXICO 230
9.5.3.1 Growth in pharmaceutical market to spur cell culture in Mexico 230
TABLE 294 MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 295 MEXICO: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 296 MEXICO: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 231
TABLE 297 MEXICO: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 298 MEXICO: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 299 MEXICO: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 232
9.5.4 REST OF LATIN AMERICA 233
TABLE 300 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 301 REST OF LATIN AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 302 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 234
TABLE 303 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 304 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 305 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 235
9.6 MIDDLE EAST & AFRICA 236
9.6.1 GROWING FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS TO PROPEL MARKET 236
9.6.2 RECESSION IMPACT 236
TABLE 306 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 307 MIDDLE EAST & AFRICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 308 MIDDLE EAST AND AFRICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 238
TABLE 309 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 310 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 311 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION) 239
10 COMPETITIVE LANDSCAPE 240
10.1 INTRODUCTION 240
10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 241
FIGURE 30 CELL CULTURE MEDIA MARKET: STRATEGIES ADOPTED 241
10.3 MARKET SHARE ANALYSIS 242
FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) 242
TABLE 312 CELL CULTURE MEDIA MARKET: DEGREE OF COMPETITION 242
10.4 REVENUE SHARE ANALYSIS 244
FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS (2019–2022) 244
10.5 COMPANY EVALUATION QUADRANT 245
10.5.1 STARS 245
10.5.2 EMERGING LEADERS 245
10.5.3 PERVASIVE PLAYERS 245
10.5.4 PARTICIPANTS 246
FIGURE 33 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION MATRIX, 2022 246
10.6 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS 247
10.6.1 PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES) 247
TABLE 313 CELL CULTURE MEDIA MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 247
10.6.2 REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES) 248
TABLE 314 CELL CULTURE MEDIA MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 248
10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 249
10.7.1 PROGRESSIVE COMPANIES 249
10.7.2 RESPONSIVE COMPANIES 249
10.7.3 DYNAMIC COMPANIES 249
10.7.4 STARTING BLOCKS 249
FIGURE 34 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 250
10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 251
TABLE 315 CELL CULTURE MEDIA MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS 251
TABLE 316 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION QUADRANT OF START-UP/SME PLAYERS 252
10.9 COMPETITIVE SCENARIO AND TRENDS 253
10.9.1 PRODUCT LAUNCHES 253
TABLE 317 CELL CULTURE MEDIA MARKET: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023 253
10.9.2 DEALS 254
TABLE 318 CELL CULTURE MEDIA MARKET: DEALS, JANUARY 2020 TO JUNE 2023 254
10.9.3 OTHER DEVELOPMENTS 255
TABLE 319 CELL CULTURE MEDIA MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO JUNE 2023 255
11 COMPANY PROFILES 256
(Business overview, Products offered, Recent developments & MnM View)*
11.1 KEY PLAYERS 256
11.1.1 THERMO FISHER SCIENTIFIC INC. 256
TABLE 320 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 256
FIGURE 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 257
TABLE 321 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES 260
TABLE 322 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS 261
11.1.2 MERCK KGAA 262
TABLE 323 MERCK KGAA: COMPANY OVERVIEW 262
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2022) 263
TABLE 324 MERCK KGAA: DEALS 264
11.1.3 DANAHER 265
TABLE 325 DANAHER: COMPANY OVERVIEW 265
FIGURE 37 DANAHER: COMPANY SNAPSHOT (2022) 266
TABLE 326 DANAHER: DEALS 269
TABLE 327 DANAHER: OTHER DEVELOPMENTS 269
11.1.4 SARTORIUS AG 270
TABLE 328 SARTORIUS AG: BUSINESS OVERVIEW 270
FIGURE 38 SARTORIUS AG: COMPANY SNAPSHOT (2022) 271
TABLE 329 SARTORIUS AG: PRODUCT LAUNCHES 273
TABLE 330 SARTORIUS AG: DEALS 273
TABLE 331 SARTORIUS AG: OTHER DEVELOPMENTS 274
11.1.5 CORNING INCORPORATED 275
TABLE 332 CORNING INCORPORATED: BUSINESS OVERVIEW 275
FIGURE 39 CORNING INCORPORATED: COMPANY SNAPSHOT (2022) 276
11.1.6 FUJIFILM HOLDINGS CORPORATION 278
TABLE 333 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 278
FIGURE 40 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022) 279
TABLE 334 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES 280
TABLE 335 FUJIFILM HOLDINGS CORPORATION: DEALS 281
TABLE 336 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS 281
11.1.7 LONZA 282
TABLE 337 LONZA: BUSINESS OVERVIEW 282
FIGURE 41 LONZA: COMPANY SNAPSHOT (2022) 283
TABLE 338 LONZA: PRODUCT LAUNCHES 284
TABLE 339 LONZA: OTHER DEVELOPMENTS 284
11.1.8 BECTON, DICKINSON AND COMPANY (BD) 285
TABLE 340 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 285
FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 286
11.1.9 STEMCELL TECHNOLOGIES 288
TABLE 341 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW 288
TABLE 342 STEMCELL TECHNOLOGIES: DEALS 289
11.1.10 MILTENYI BIOTEC 290
TABLE 343 MILTENYI BIOTEC: BUSINESS OVERVIEW 290
11.1.11 HIMEDIA LABORATORIES 292
TABLE 344 HIMEDIA LABORATORIES: BUSINESS OVERVIEW 292
11.1.12 BIOLOGOS 293
TABLE 345 BIOLOGOS: BUSINESS OVERVIEW 293
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 294
11.2.1 CELL APPLICATIONS, INC. 294
TABLE 346 CELL APPLICATIONS, INC.: COMPANY OVERVIEW 294
11.2.2 CAISSON LABS INC. 295
TABLE 347 CAISSON LABS INC.: COMPANY OVERVIEW 295
11.2.3 PROMOCELL GMBH 296
TABLE 348 PROMOCELL GMBH: COMPANY OVERVIEW 296
11.2.4 CELL BIOLOGICS, INC. 297
TABLE 349 CELL BIOLOGICS, INC.: COMPANY OVERVIEW 297
11.2.5 INVIVOGEN 298
TABLE 350 INVIVOGEN: COMPANY OVERVIEW 298
11.2.6 PAN-BIOTECH 299
TABLE 351 PAN-BIOTECH: COMPANY OVERVIEW 299
11.2.7 CELLULAR TECHNOLOGY LIMITED 300
TABLE 352 CELLULAR TECHNOLOGY LIMITED: COMPANY OVERVIEW 300
11.2.8 ZENBIO, INC. 301
TABLE 353 ZENBIO, INC.: COMPANY OVERVIEW 301
11.2.9 ATHENA ENVIRONMENTAL SCIENCES, INC. 302
TABLE 354 ATHENA ENVIRONMENTAL SCIENCES, INC.: COMPANY OVERVIEW 302
11.2.10 CYAGEN BIOSCIENCES 303
TABLE 355 CYAGEN BIOSCIENCES: COMPANY OVERVIEW 303
11.2.11 BIOWEST 304
TABLE 356 BIOWEST: COMPANY OVERVIEW 304
11.2.12 AKRON BIOTECH 305
TABLE 357 AKRON BIOTECH.: COMPANY OVERVIEW 305
11.2.13 KCELL BIOSCIENCES 305
TABLE 358 KCELL BIOSCIENCES: COMPANY OVERVIEW 305
11.2.14 WELGENE INC. 307
TABLE 359 WELGENE INC.: COMPANY OVERVIEW 307
12 APPENDIX 308
12.1 DISCUSSION GUIDE 308
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 312
12.3 CUSTOMIZATION OPTIONS 314
12.4 RELATED REPORTS 314
12.5 AUTHOR DETAILS 315

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 細胞培養培地の世界市場予測（～2028）：種類別、用途別、エンドユーザー別、地域別(Cell Culture Media Market by Type (Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application (Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User (Pharma, Biotech) & Region - Global Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

細胞培養培地の世界市場予測（～2028）：種類別、用途別、エンドユーザー別、地域別

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp